Navigation Links
GAB Robins Names Gail Oliver as Vice President, Loss Adjusting Sales
Date:11/28/2007

PARSIPPANY, N.J., Nov. 28 /PRNewswire/ -- GAB Robins is pleased to announce that Gail Oliver has been named Vice President of Loss Adjusting Sales for North American Operations. In this position, Ms. Oliver will lead and manage the Loss Adjusting sales team and will be responsible for increasing business development opportunities for this aspect of the company's portfolio.

Ms. Oliver has been with GAB Robins for seven years. Most recently, she has been serving as the Regional Vice President for the GAB Robins' Northeast Region, operationally responsible for the region's network of office locations.

"She has contributed significantly to revenue growth, client retention and claim quality improvement," said Peter Harn, Executive Vice President of Business Development for GAB Robins' North American Operations. "She is well known within the industry, and, I believe, will make an immediate impact in her new position."

In addition to her experience with GAB Robins, Ms. Oliver worked as a Property Claims Director for CSE Insurance Group and as a Vice President for Ward North America. She holds a bachelor's degree from The Pennsylvania State University and the Associate in Claims designation from the Insurance Institute of America. In addition, Ms. Oliver is accredited as a Property Claims Law Associate from the American Educational Institute.

GAB Robins is a leading provider of global risk management services and solutions to the insurance and self-insured marketplace with affiliated operations in 58 countries. For more information, visit http://www.gabrobins.com.


'/>"/>
SOURCE GAB Robins
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
6. Patient Safety Authority Board of Directors Names Infection Advisory Panel
7. Hooper Holmes Names Chris Behling President of Health & Wellness Division
8. MDMA Names New Director of Federal Affairs
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: